Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19
Abstract Vitamin D deficiency (VDD) owing to its immunomodulatory effects is believed to influence outcomes in COVID-19. We conducted a prospective, observational study of patients, hospitalized with COVID-19. Serum 25-OHD level < 20 ng/mL was considered VDD. Patients were classified as having mi...
Saved in:
Main Authors: | Ganesh Jevalikar, Ambrish Mithal, Anshu Singh, Rutuja Sharma, Khalid J. Farooqui, Shama Mahendru, Arun Dewan, Sandeep Budhiraja |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/1476d0fbc9b54c9c9febad184eeb46a1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low FT3 is an independent marker of disease severity in patients hospitalized for COVID-19
by: Aditya Dutta, et al.
Published: (2021) -
Serum 25-hydroxyvitamin D predicts cognitive performance in adults
by: Darwish H, et al.
Published: (2015) -
Comparison of Serum 25-Hydroxyvitamin D Levels in Children with and without Intussusception
by: MR Esmaeili Doki, et al.
Published: (2020) -
Development and analytical validation of a novel bioavailable 25-hydroxyvitamin D assay.
by: Anders H Berg, et al.
Published: (2021) -
Serum 25-hydroxyvitamin D concentration in Children with Lower Respiratory Tract Infection
by: Asmaa Salah Barania, et al.
Published: (2020)